DataMEDS AI Inc.
MEDS | NASDAQ
$1.89
-$0.03 (-1.56%)
Nov 2, 2026, 12:20 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -18.36M | -7.74M | -27.85M | -34.32M | -6.67M | -32.43M | -4.33M | -1.87M | -574.33K | -6.64M | -1.08M | -903.31K |
Depreciation & Amortization | 2.04M | 356.82K | 802.6K | 802.79K | 802.8K | 802.87K | 647.24K | 454.63K | 12.79K | 8.3K | n/a | n/a |
Stock-Based Compensation | 1.2M | 1.36M | 355.7K | 25.73M | 935.22K | 27.77M | n/a | n/a | n/a | 24.27K | n/a | n/a |
Other Working Capital | 2.1M | -154K | 1.13M | 1.33M | 209.69K | 926.79K | 622.76K | 3.11M | 752.05K | -6.96M | 55.13K | 808K |
Other Non-Cash Items | 9.33M | 1.32M | 21.87M | 1.83M | 135.6K | 98.26K | 1.15M | 26.67K | n/a | 3.92M | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.89M | 1.3M | -1.47M | 4.82M | 2.72M | 2.41M | -122.94K | 2.42M | 639.31K | -7.51M | 614.1K | 1.02M |
Operating Cash Flow | -2.89M | -3.41M | -6.29M | -1.14M | -2.08M | -1.35M | -2.66M | 1.04M | 77.77K | -10.19M | -462.06K | 112.94K |
Capital Expenditures | 205.1K | -205.1K | -255.38K | 405.06K | -131.93K | -273.13K | -112.44K | -217.05K | -4 | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 1M | -98.89K | 30.26K | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.5M | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -447.23K | n/a | n/a | -626.14K | n/a | n/a | -49.15K | n/a | -35.86K | 29.93M | n/a | n/a |
Investing Cash Flow | -242.13K | -205.1K | -255.38K | -221.09K | -131.93K | -273.13K | 838.41K | -315.94K | -53.4K | 27.43M | n/a | n/a |
Debt Repayment | 6.7M | 5.82M | -565K | -1.38M | -606.14K | 235.87K | 904.22K | -283.52K | -250K | n/a | 350K | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12.67M | n/a | n/a |
Other Financial Acitivies | n/a | -2.19M | 2.93M | n/a | 152.7K | -1.13M | 1.31M | 288.04K | n/a | -1.25M | n/a | n/a |
Financial Cash Flow | 5.54M | 3.63M | 2.36M | 5.17M | 114.28K | 3.11M | 2.06M | 4.52K | -250K | -13.9M | 350K | n/a |
Net Cash Flow | 2.4M | 9.16K | -4.19M | 3.81M | -2.1M | 1.49M | 235.19K | 726.17K | -225.63K | 3.35M | -112.06K | 112.94K |
Free Cash Flow | -2.69M | -3.62M | -6.55M | -730.27K | -2.21M | -1.62M | -2.77M | 820.54K | 77.77K | -10.19M | -462.06K | 112.94K |
Adj. Free Cash Flow | -3.89M | -4.98M | -6.9M | -26.46M | -3.15M | -29.39M | -2.77M | 820.54K | 77.77K | -10.21M | -462.06K | 112.94K |
Maintenance CapEx | -205.1K | -205.1K | -255.38K | 405.06K | -131.93K | -150.53K | -112.44K | -3.49K | n/a | n/a | n/a | n/a |
Growth CapEx | 410.2K | n/a | n/a | n/a | n/a | -122.6K | n/a | -213.56K | -4 | n/a | n/a | n/a |
Owner Earnings | -3.1M | -3.62M | -6.55M | -730.27K | -2.21M | -1.5M | -2.77M | 1.03M | 77.77K | -10.19M | -462.06K | 112.94K |
Add to Watchlist
Select watchlists to add or remove MEDS